Overexpression of STAT-1 by adenoviral gene transfer does not inhibit hepatitis B virus replication

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 2, 2006, Pages 167-174

  Siebler, Jürgen ^a   Protzer, Ulrike ^b   Wirtz, Stefan ^a   Schuchmann, Marcus ^a   Höhler, Thomas ^a   Galle, Peter R ^a   Neurath, Markus F ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Hepatitis B virus; Interferon; STAT 1

Indexed keywords

GAMMA INTERFERON; STAT1 PROTEIN; VIRUS DNA; VIRUS PROTEIN;

ADENOVIRUS VECTOR; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; DUCK; GENE TRANSFER; HEPATITIS B VIRUS; HEPATITIS VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INHIBITION; VIRUS REPLICATION; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELLS, CULTURED; DNA, VIRAL; DUCKS; GENE EXPRESSION REGULATION; GENETIC VECTORS; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; STAT1 TRANSCRIPTION FACTOR; TRANSFECTION; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

EID: 33644840990     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200602000-00009     Document Type: Article

References (35)

1. Guidotti LG, Matzke B, Schaller H, Chisari FV. High-level hepatitis B virus replication in transgenic mice. J Virol 1995; 69:6158-6169.
2. Guidotti LG, Chisari FV. Cytokine-induced viral purging - role in viral pathogenesis. Curr Opin Microbiol 1999; 2:388-391.
3. McClary H, Koch R, Chisari FV, Guidotti LG. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J Virol 2000; 74:2255-2264.
4. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4:25-36.
5. Tsui LV, Guidotti LG, Ishikawa T, Chisari FV. Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. Proc Natl Acad Sci USA 1995; 92:12398-12402.
6. Klocker U, Schultz U, Schaller H, Protzer U. Endotoxin stimulates liver macrophages to release mediators that inhibit an early step in hepadnavirus replication. J Virol 2000; 74:5525-5533.
7. Uprichard SL, Wieland SF, Althage A, Chisari FV. Transcriptional and posttranscriptional control of hepatitis B virus gene expression. Proc Natl Acad Sci USA 2003; 100:1310-1315.
8. Cavanaugh VJ, Guidotti LG, Chisari FV. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J Virol 1997; 71:3236-3243.
9. Cavanaugh VJ, Guidotti LG, Chisari FV. Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice. J Virol 1998; 72:2630-2637.
10. Robek MD, Boyd BS, Wieland SF, Chisari FV. Signal transduction pathways that inhibit hepatitis B virus replication. Proc Natl Acad Sci USA 2004; 101:1743-1747.
11. Boehm U, Guethlein L, Klamp T, Ozbek K, Schaub A, Futterer A, et al. Two families of GTPases dominate the complex cellular response to IFN-gamma. J Immunol 1998; 161:6715-6723.
12. Der SD, Zhou A, Williams BR, Silverman RH. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 1998; 95:15623-15628.
13. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264:1415-1421.
14. Schindler C, Darnell JE, Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 1995; 64:621-651.
15. Wen Z, Zhong Z, Darnell JE, Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995; 82:241-250.
16. Zhu X, Wen Z, Xu LZ, Darnell JE, Jr. Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase. Mol Cell Biol 1997; 17:6618-6623.
17. Zhang X, Blenis J, Li HC, Schindler C, Chen-Kiang S. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 1995; 267:1990-1994.
18. Durbin JE, Hackenmiller R, Simon MC, Levy DE. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 1996; 84:443-450.
19. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996; 84:431-442.
20. Townsend PA, Scarabelli TM, Davidson SM, Knight RA, Latchman DS, Stephanou A. STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis. J Biol Chem 2004; 279:5811-5820.
21. Strehlow I, Seegert D, Frick C, Bange FC, Schindler C, Bottger EC, et al. The gene encoding IFP 53/tryptophanyl-tRNA synthetase is regulated by the gamma-interferon activation factor. J Biol Chem 1993; 268: 16590-16595.
22. Woldman I, Varinou L, Ramsauer K, Rapp B, Decker T. The Stat1 binding motif of the interferon-gamma receptor is sufficient to mediate Stat5 activation and its repression by SOCS3. J Biol Chem 2001; 276: 45722-45728.
23. Siebler J, Wirtz S, Klein S, Protschka M, Blessing M, Galle PR, et al. A key pathogenic role for the STAT1/T-bet signaling pathway in T-cell-mediated liver inflammation. Hepatology 2003; 38:1573-1580.
24. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95:2509-2514.
25. Wirtz S, Galle PR, Neurath MF. Efficient gene delivery to the inflamed colon by local administration of recombinant adenoviruses with normal or modified fibre structure. Gut 1999; 44:800-807.
26. Galle PR, Schlicht HJ, Kuhn C, Schaller H. Replication of duck hepatitis B virus in primary duck hepatocytes and its dependence on the state of differentiation of the host cell. Hepatology 1989; 10:459-465.
27. Protzer U, Nassal M, Chiang PW, Kirschfink M, Schaller H. Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection. Proc Natl Acad Sci USA 1999; 96: 10818-10823.
28. Schlicht HJ, Salfeld J, Schaller H. The duck hepatitis B virus pre-C region encodes a signal sequence which is essential for synthesis and secretion of processed core proteins but not for virus formation. J Virol 1987; 61: 3701-3709.
29. Price PM, Banerjee R, Acs G. Inhibition of the replication of hepatitis B virus by the carbocyclic analogue of 2′-deoxyguanosine. Proc Natl Acad Sci USA 1989; 86:8541-8544.
30. Muller M, Ibelgaufts H, Kerr IM. Interferon response pathways - a paradigm for cytokine signalling? J Viral Hepat 1994; 1:87-103.
31. Yamada K, Ariyoshi K, Onishi M, Miyajima A, Hayakawa F, Towatari M, et al. Constitutively active STAT5A and STAT5B in vitro and in vivo: mutation of STAT5 is not a frequent cause of leukemogenesis. Int J Hematol 2000; 71:46-54.
32. Ariyoshi K, Nosaka T, Yamada K, Onishi M, Oka Y, Miyajima A, et al. Constitutive activation of STAT5 by a point mutation in the SH2 domain. J Biol Chem 2000; 275:24407-24413.
33. Kamogawa Y, Lee HJ, Johnston JA, McMahon M, O'Garra A, Arai N. A conditionally active form of STAT6 can mimic certain effects of IL-4. J Immunol 1998; 161:1074-1077.
34. Milocco LH, Haslam JA, Rosen J, Seidel HM. Design of conditionally active STATs: insights into STAT activation and gene regulatory function. Mol Cell Biol 1999; 19:2913-2920.
35. Napper S, Anderson JW, Georges F, Quail JW, Delbaere LT, Waygood EB. Mutation of serine-46 to aspartate in the histidine-containing protein of Escherichia coli mimics the inactivation by phosphorylation of serine-46 in HPrs from gram-positive bacteria. Biochemistry 1996; 35:11260-11267.